Yunxia Zuo

Summary

Publications

  1. pmc Mutations in epidermal growth factor receptor and K-ras in Chinese patients with colorectal cancer
    Zuo Yunxia
    Department of Medical Oncology, Fudan University Cancer Hospital, Shanghai Medical School, Shanghai 200032, PR China
    BMC Med Genet 11:34. 2010
  2. pmc Safety and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor YN968D1 in patients with advanced malignancies
    Jin Li
    Department of Medical Oncology, Fudan University Shanghai Cancer Center, PR China
    BMC Cancer 10:529. 2010

Collaborators

  • Jin Li
  • Zuo Yunxia
  • Ka Jia
  • Zhu Guanshan
  • Zhou Xueke
  • Chuan Li
  • Chunlei Zheng
  • Fengqing Wang
  • Li Jin
  • Cao Jun
  • Xinmin Zhao
  • Jun Qian
  • Haiyi Guo
  • Fangfang Lv
  • Ke Yv
  • Lei Chen
  • Lu Yachao

Detail Information

Publications2

  1. pmc Mutations in epidermal growth factor receptor and K-ras in Chinese patients with colorectal cancer
    Zuo Yunxia
    Department of Medical Oncology, Fudan University Cancer Hospital, Shanghai Medical School, Shanghai 200032, PR China
    BMC Med Genet 11:34. 2010
    ..Data on the gene mutation status of EGFR and K-ras in Chinese patients with CRC are limited...
  2. pmc Safety and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor YN968D1 in patients with advanced malignancies
    Jin Li
    Department of Medical Oncology, Fudan University Shanghai Cancer Center, PR China
    BMC Cancer 10:529. 2010
    ..The study was conducted to determine the maximum tolerated dose (MTD), safety profile, pharmacokinetic variables, and antitumor activity in advanced solid malignancies...